Search research articles
Contact Us
Filters
Showing results (1-10 of 17) with videos related to
Page
of 2
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 16, 2023
POSing the question: MARIPOSA-2, do the ends justify the means?
M F Chen, Z Piotrowska, H A Yu
Proteins
|
June 1, 1993
Active site dynamics of acyl-chymotrypsin
S Nakagawa, H A Yu, M Karplus, et al.
Forensic Science International
|
March 2, 2017
Fundamental studies of the adhesion of explosives to textile and non-textile surfaces
H A Yu, T Becker, N Nic Daeid, et al.
Talanta
|
January 22, 2017
The stability of TNT, RDX and PETN in simulated post-explosion soils: Implications of sample preparation for analysis
H A Yu, D A DeTata, S W Lewis, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 31, 2014
Poor response to erlotinib in patients with tumors containing baseline EGFR T790M mutations found by routine clinical molecular testing
H A Yu, M E Arcila, M D Hellmann, et al.
Journal of Molecular Biology
|
July 17, 1998
Solution structure and membrane interactions of the C2 domain of cytosolic phospholipase A2
G Y Xu, T McDonagh, H A Yu, et al.
Journal of Molecular Biology
|
May 2, 1997
Solution structure of recombinant human interleukin-6
G Y Xu, H A Yu, J Hong, et al.
Archives of Biochemistry and Biophysics
|
October 1, 1987
Polyethylene glycol-induced heteroassociation of malate dehydrogenase and citrate synthase
J M Merz, T A Webster, J R Appleman, et al.
Cancer
|
June 23, 2015
Epidermal growth factor receptor exon 20 insertions in advanced lung adenocarcinomas: Clinical outcomes and response to erlotinib
J Naidoo, C S Sima, K Rodriguez, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 12, 2017
Phase 1 study of twice weekly pulse dose and daily low-dose erlotinib as initial treatment for patients with EGFR-mutant lung cancers
H A Yu, C Sima, D Feldman, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 17) with videos related to
Sort By:
Page
of 2
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 16, 2023
POSing the question: MARIPOSA-2, do the ends justify the means?
M F Chen, Z Piotrowska, H A Yu
Proteins
|
June 1, 1993
Active site dynamics of acyl-chymotrypsin
S Nakagawa, H A Yu, M Karplus, et al.
Forensic Science International
|
March 2, 2017
Fundamental studies of the adhesion of explosives to textile and non-textile surfaces
H A Yu, T Becker, N Nic Daeid, et al.
Talanta
|
January 22, 2017
The stability of TNT, RDX and PETN in simulated post-explosion soils: Implications of sample preparation for analysis
H A Yu, D A DeTata, S W Lewis, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 31, 2014
Poor response to erlotinib in patients with tumors containing baseline EGFR T790M mutations found by routine clinical molecular testing
H A Yu, M E Arcila, M D Hellmann, et al.
Journal of Molecular Biology
|
July 17, 1998
Solution structure and membrane interactions of the C2 domain of cytosolic phospholipase A2
G Y Xu, T McDonagh, H A Yu, et al.
Journal of Molecular Biology
|
May 2, 1997
Solution structure of recombinant human interleukin-6
G Y Xu, H A Yu, J Hong, et al.
Archives of Biochemistry and Biophysics
|
October 1, 1987
Polyethylene glycol-induced heteroassociation of malate dehydrogenase and citrate synthase
J M Merz, T A Webster, J R Appleman, et al.
Cancer
|
June 23, 2015
Epidermal growth factor receptor exon 20 insertions in advanced lung adenocarcinomas: Clinical outcomes and response to erlotinib
J Naidoo, C S Sima, K Rodriguez, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 12, 2017
Phase 1 study of twice weekly pulse dose and daily low-dose erlotinib as initial treatment for patients with EGFR-mutant lung cancers
H A Yu, C Sima, D Feldman, et al.
Page
of 2